» Articles » PMID: 33545035

A Pan-cancer Single-cell Transcriptional Atlas of Tumor Infiltrating Myeloid Cells

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2021 Feb 5
PMID 33545035
Citations 518
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor-infiltrating myeloid cells (TIMs) are key regulators in tumor progression, but the similarity and distinction of their fundamental properties across different tumors remain elusive. Here, by performing a pan-cancer analysis of single myeloid cells from 210 patients across 15 human cancer types, we identified distinct features of TIMs across cancer types. Mast cells in nasopharyngeal cancer were found to be associated with better prognosis and exhibited an anti-tumor phenotype with a high ratio of TNF/VEGFA cells. Systematic comparison between cDC1- and cDC2-derived LAMP3 cDCs revealed their differences in transcription factors and external stimulus. Additionally, pro-angiogenic tumor-associated macrophages (TAMs) were characterized with diverse markers across different cancer types, and the composition of TIMs appeared to be associated with certain features of somatic mutations and gene expressions. Our results provide a systematic view of the highly heterogeneous TIMs and suggest future avenues for rational, targeted immunotherapies.

Citing Articles

Single-cell transcriptomic analyses reveal heterogeneity and key subsets associated with survival and response to PD-1 blockade in cervical squamous cell carcinoma.

Li X, Zhao Z, Cheng Y, Yan J, Ren F, Jia Y Cancer Cell Int. 2025; 25(1):90.

PMID: 40082876 PMC: 11907857. DOI: 10.1186/s12935-025-03725-x.


Single-cell RNA sequencing revealed changes in the tumor microenvironment induced by radiotherapy for cervical cancer and the molecular mechanism of mast cells in immunosuppression.

Xue L, Gao L, Zhou S, Yan C, Zhang X, Lin W Funct Integr Genomics. 2025; 25(1):63.

PMID: 40082276 DOI: 10.1007/s10142-025-01564-7.


Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy.

Zhang W, Huang X Biomark Res. 2025; 13(1):43.

PMID: 40075527 PMC: 11905658. DOI: 10.1186/s40364-025-00750-w.


Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 overcomes macrophage immunosuppression in cancer.

Guc E, Treveil A, Leach E, Broomfield A, Camera A, Clubley J Nat Commun. 2025; 16(1):2374.

PMID: 40064880 PMC: 11893752. DOI: 10.1038/s41467-025-57470-w.


Single-cell analysis reveals transcriptomic features and therapeutic targets in primary pulmonary lymphoepithelioma-like carcinoma.

Tan B, Xu K, Lyu Y, Liang Y, Liang R, Lei K Commun Biol. 2025; 8(1):394.

PMID: 40057671 PMC: 11890618. DOI: 10.1038/s42003-025-07819-0.